U.S. Markets closed

EnteroMedics Inc. (ETRM)


NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
4.98+0.03 (+0.61%)
At close: 4:00PM EDT
People also watch
IDXGPULMBIOCXGTIGLBS

EnteroMedics Inc.

2800 Patton Road
St. Paul, MN 55113
United States
651-634-3003
http://www.enteromedics.com

SectorHealthcare
IndustryMedical Appliances & Equipment
Full Time Employees32

Key Executives

NameTitlePayExercisedAge
Mr. Dan W. GladneyChairman, Chief Exec. Officer and Pres463.72kN/A64
Dr. Mark B. Knudson Ph.D.Co-Founder and Special Advisor to the CEON/AN/A68
Mr. Scott P. YoungstromChief Financial Officer, Chief Compliance Officer and Sec.65.42kN/A57
Mr. Peter M. DeLange MBASr. VP of Operations and Bus. Devel.283.15kN/A48
Mr. Paul F. HickeySr. VP of Marketing and Reimbursement282.8kN/A52
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

EnteroMedics Inc., a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. Its proprietary neuroblocking technology, vBloc Therapy is designed to intermittently block the vagus nerve using electrical impulses. The company develops the vBloc System, which is used to limit the expansion of the stomach, control hunger sensations between meals, reduce the frequency and intensity of stomach contractions, and produce a feeling of early and prolonged fullness. It has collaboration with Mayo Clinic. The company was formerly known as Beta Medical, Inc. and changed its name to EnteroMedics Inc. in 2003. EnteroMedics Inc. was founded in 2002 and is headquartered in St. Paul, Minnesota.

Corporate Governance

EnteroMedics Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.